Abstract
Our objective was to identify the sites of interaction of cannabinoids with cardiovascular sympathetic regulation in the rat. Effects on sympathetic tone were first determined in anaesthetised animals following i.v. administration of the drugs. Central effects were evaluated in anaesthetised rats receiving microinjections of cannabinoids into brain stem nuclei. Peripheral effects were identified in pithed rats with electrically stimulated sympathetic outflow.
In anaesthetised and artificially ventilated rats, i.v. injection of the cannabinoid agonists WIN55212-2 and CP55940 decreased mean arterial pressure, heart rate and the plasma noradrenaline concentration. These effects were antagonized by the CB1 cannabinoid receptor antagonist SR141716A. The bradycardia was abolished by the muscarinic acetylcholine receptor antagonist methylatropine. The decreases in mean arterial pressure and heart rate caused by cannabinoids in ventilated rats were much less pronounced than in spontaneously breathing rats. Microinjection of WIN55212-2 into the nucleus tractus solitarii had no effect. Microinjected into the rostral ventrolateral medulla oblongata, WIN55212-2 lowered mean arterial pressure slightly without changing other parameters. In pithed rats, WIN55212-2 inhibited the increases in mean arterial pressure, heart rate and the plasma noradrenaline concentration evoked by electrical stimulation of the sympathetic outflow.
Our results show that activation of CB1 cannabinoid receptors induces sympathoinhibition and enhancement of cardiac vagal tone, leading to hypotension and bradycardia. Presynaptic inhibition of noradrenaline release from terminals of postganglionic sympathetic neurons is the major component of the sympathoinhibition, but an effect in the rostral ventrolateral medulla oblongata may also contribute. The cannabinoid-evoked cardiovascular depression depends strongly on the respiratory state of the animals.
Similar content being viewed by others
References
Benowitz NL, Rosenberg J, Rogers W, Bachman J, Jones RT (1979) Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: autonomic nervous mechanisms. Clin Pharmacol Ther 25:440–446
Carruba MO, Bondiolotti G, Picotti GB, Catteruccia N, Da Prada M (1987) Effects of diethyl ether, halothane, ketamine and urethane on sympathetic activity in the rat. Eur J Pharmacol 134:15–24
Cavero I, Kubena RK, Dziak J, Buckley JP, Jandhyala BS (1972) Certain observations on the interrelationships between respiratory and cardiovascular effects of (−)-Δ9-trans-tetrahydrocannabinol. Res Commun Chem Pathol Pharmacol 3:483–492
Cavero I, Solomon T, Buckley JP, Jandhyala BS (1973a) Studies on the hypotensive activity of (−)-Δ9-trans-tetrahydrocannabinol in anesthetized dogs. Res Commun Chem Pathol Pharmacol 6:527–540
Cavero I, Solomon T, Buckley JP, Jandhyala BS (1973b) Studies on the bradycardia induced by (−)-Δ9-trans-tetrahydrocannabinol in anesthetized dogs. Eur J Pharmacol 22:263–269
Compton DR, Harris LS, Lichtman AH, Martin BR (1996) Marihuana. In: Schuster CR, Kuhar MJ (eds) Pharmacological aspects of drug dependence (Handbook of experimental pharmacology series). Springer, Berlin Heidelberg New York, pp 83–158
Dampney RAL (1994a) Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 74:323–364
Dampney RAL (1994b) The subretrofacial vasomotor nucleus: anatomical, chemical and pharmacological properties and role in cardiovascular regulation. Prog Neurobiol 42:197–227
Deutsch DG, Goligorsky MS, Schmid PC, Krebsbach RJ, Schmid HHO, Das SK, Dey SK, Arreaza G, Thorup C, Stefano G, Moore LC (1997) Production and physiological actions of anandamide in the vasculature of the rat kidney. J Clin Invest 100:1538–1546
Doherty PA, McCarthy LE, Borison HL (1983) Respiratory and cardiovascular depressant effects of nabilone, N-methyllevonantradol and Δ9-tetrahydrocannabinol in anesthetized cats. J Pharmacol Exp Ther 227:508–516
Flecknell PA (1996) Laboratory animal anaesthesia, 2nd Edn. Academic Press, London, p 91
Fredericks AB, Benowitz NL, Savanapridi CY (1981) The cardiovascular and autonomic effects of repeated administration of Δ-9-tetrahydrocannabinol to rhesus monkeys. J Pharmacol Exp Ther 216:247–253
Graham JDP, Li DMF (1973) Cardiovascular and respiratory effects of cannabis in cat and rat. Br J Pharmacol 49:1–10
Himmi T, Perrin J, Ouazzani TE, Orsini JC (1998) Neuronal responses to cannabinoid receptor ligands in the solitary tract nucleus. Eur J Pharmacol 359:49–54
Huestis MA, Sampson AH, Holicky BJ, Henningfield JE, Cone EJ (1992) Characterization of the absorption phase of marijuana smoking. Clin Pharmacol Ther 52:31–41
Ishac EJN, Jiang L, Lake KD, Varga K, Abood ME, Kunos G (1996) Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br J Pharmacol 118:2023–2028
Ito S, Sved AF (1997) Tonic glutamate-mediated control of rostral ventrolateral medulla and sympathetic vasomotor tone. Am J Physiol 273:R487–R494
Kunos G, Jarai Z, Varga K, Liu J, Wang L, Wagner JA (2000) Cardiovascular effects of endocannabinoids—the plot thickens. Prostaglandins Other Lipid Mediat 61:71–84
Lake KD, Martin BR, Kunos G, Varga K (1997a) Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension 29:1204–1210
Lake KD, Compton DR, Varga K, Martin BR, Kunos G (1997b) Cannabinoid-induced hypotension and bradycardia in rats is mediated by CB1-like cannabinoid receptors. J Pharmacol Exp Ther 281:1030–1037
Mailleux P, Vanderhaeghen JJ (1992) Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48:655–668
Malinowska B, Godlewski G, Bucher B, Schlicker E (1997) Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat. Naunyn-Schmiedeberg's Arch Pharmacol 356:197–202
Malinowska B, Piszcz J, Koneczny B, Hryniewicz A, Schlicker E (2001) Modulation of the cardiac autonomic transmission of pithed rats by presynaptic opioid OP4 and cannabinoid CB1 receptor. Naunyn-Schmiedeberg's Arch Pharmacol 364:233–241
Malit LE, Johnstone RE, Bourke DI, Kulp MS, Klein V, Smith TC (1975) Intravenous Δ9-tetrahydrocannabinol: effects on ventilatory control and cardiovascular dynamics. Anesthesiology 42:666–673
Martin WJ, Coffin PO, Attias E, Balinsky M, Tsou K, Walker JM (1999) Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections. Brain Res 822:237–242
Moss IR, Friedman E (1976) Δ9-Tetrahydrocannabinol: depression of ventilatory regulation; other respiratory and cardiovascular effects. Life Sci 19:99–104
Niederhoffer N, Szabo B (1999) Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation. Br J Pharmacol 126:457–466
Niederhoffer N, Szabo B (2000) Cannabinoids cause central sympathoexcitation and bradycardia in rabbits. J Pharmacol Exp Ther 294:707–713
Osgood PF, Howes JF (1977) Δ9-Tetrahydrocannabinol and dimethylheptylpyran induced tachycardia in the conscious rat. Life Sci 21:1329–1336
Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. 2nd Edn. Academic Press, New York
Szabo B, Nordheim U, Niederhoffer N (2001a) Effects of cannabinoids on sympathetic and parasympathetic neuroeffector transmission in the rabbit heart. J Pharmacol Exp Ther 297:819–826
Szabo B, Fritz T, Wedzony K (2001b) Effects of imidazoline antihypertensive drugs on sympathetic tone and noradrenaline release in the prefrontal cortex. Br J Pharmacol 134:295–304
Szabo B, Pfitzer T, Niederhoffer N (2002) Central respiratory effects of cannabinoids in rats (abstract). 2002 Symposium on the cannabinoids. International Cannabinoid Research Society, Burlington Vermont, p 157
Varga K, Lake K, Martin BR, Kunos G (1995) Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur J Pharmacol 278:279–283
Varga K, Lake K, Huangfu D, Guyenet PG, Kunos G (1996) Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension 28:682–686
Vidrio H, Sanchez-Salvatori MA, Medina M (1996) Cardiovascular effects of (−)-11-OH-Δ8-tetrahydrocannabinol-dimethylheptyl in rats. J Cardiovasc Pharmacol 28:332–336
Vivian JA, Kishioka S, Butelman ER, Broadbear J, O´Lee K, Woods JH (1998) Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in Rhesus monkeys: antagonist effects of SR141716A. J Pharmacol Exp Ther 286:697–703
Vollmer RR, Cavero I, Ertel RJ, Solomon TA, Buckley JP (1974) Role of the central autonomic nervous system in the hypotension and bradycardia induced by (−)-Δ9-trans-tetrahydrocannabinol. J Pharm Pharmacol 26:186–192
Wagner JA, Varga K, Kunos G (1998) Cardiovascular actions of cannabinoids and their generation during shock. J Mol Med 76:824–836
Acknowledgements
The study was supported by the Deutsche Forschungsgemeinschaft (Sz 72/2-3 and Ni 644/1-1). The support and advice of Klaus Starke are gratefully acknowledged. We thank Pfizer (Groton, CT, USA) and Sanofi Recherche (Montpellier, France) for generous supply of CP55940 and SR141716A, respectively. We also thank Claudia Schurr for her help with the HPLC analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Niederhoffer, N., Schmid, K. & Szabo, B. The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression. Naunyn-Schmiedeberg's Arch Pharmacol 367, 434–443 (2003). https://doi.org/10.1007/s00210-003-0755-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-003-0755-y